| Institution | Name | Role in EMI-TB |
|---|---|---|
 |
St George's, University of London, UK PI: Dr Rajko Reljic |
Comparative testing of mucosal vaccine candidates, immune response analysis, coordination and management |
 |
King's College London, UK PI: Prof. Juraj Ivanyi |
Testing of peptide epitopes |
 |
Karolinska Institutet, Sweden PI: Prof. Martin Rottenberg |
Testing of vaccine candidates, correlates of protection |
 |
Universidade De Vigo, Spain PI: Prof. Africa Gonzalez-Fernandez |
Provision and immunological analysis of clinical samples, correlates of protection |
 |
LIONEX GmbH CEO: Prof. Mahavir Singh |
Provision of recombinant fusion proteins |
 |
Azienda Ospedialiera Universitaria Policlinico Paolo Giaccone Palermo, Italy PI: Prof. Francesco Dieli |
Identification of novel T-cell epitopes |
 |
Sporegen Ltd. CEO: Prof. Simon Cutting |
Provision and optimisation of Bacillus subtilis spores |
 |
Stockholms Universitat, Sweden PI: Prof. Carmen Fernandez |
Innate immune correlates of protection |
 |
CSIC, Spain PI: Dr. Mónica Carrera |
Proteomic analysis of clinical samples |
 |
Universita degli Studi di Roma Tor Vergana, Italy PI: Prof. Maurizio Fraziano |
Provision of liposomes for the delivery of T-cell epitopes |
 |
IGTP, Spain PI: Prof. Pere-Joan Cardona |
Testing of vaccine candidates |
 |
Public Health England, UK PI: Dr Sally Sharpe |
Testing of vaccine candidates |
 |
Instituto Nacionale do Saude, Mozambique PI: Dr Tufaria Mussa |
Provision of clinical samples |
 |
IMIC, Czech Republic PI: Prof. Peter Sebo |
Provision of vaccine delivery systems |